Health

Results: 4921-4932 of 6190

FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro

Vector Laboratories and Navinci Diagnostics Announce Strategic Collaboration to Develop Novel Spatial Proteomic Tools Enabling Biomarker Discovery

Huxley Health Inc. Provides Corporate Update - Appoints Bruce Linton as Chairman

Vect-Horus Enters Exclusive License Agreement with Ionis Pharmaceuticals to Advance Systemic Delivery of RNA-Targeted Medicines for Neurological Diseases

XtalPi Unveils Ailux: A New Chapter in AI-Powered Biologics Discovery

PR Newswire associated0

LAUNCH OF TSC LIFE THROUGH THE MERGER OF THE SURGICAL COMPANY'S PATIENT TEMPERATURE MANAGEMENT AND SINGLE-USE ENDOSCOPY BUSINESSES

Figure 1: Mean NPRS Over Time in Phase 3 Study of Acute Pain Following Abdominoplasty (Graphic: Business Wire)

Vertex Announces Positive Results From the VX-548 Phase 3 Program for the Treatment of Moderate-to-Severe Acute Pain

Delta-Fly Pharma Inc.: Update on the Interim Analysis Status of Phase III Study of DFP-10917 in the patients with R/R AML

IPS UK Open a New Office in Manchester. Glen Slaymaker - IPS UK Director & Dennis Wareing - Director of Risk & Compliance cut the ribbon to open the new office. (Photo: Business Wire)

IPS Expands European Presence with Second Location in the UK

Gilda D’Incerti, PQE Group CEO & Founder (Photo: Business Wire)

PQE Group: 100+M€ in Revenues

PR Newswire associated0

Results of the Phase III INSPIRE Study on Qilu Pharmaceutical's Iruplinalkib Published in the Journal of Thoracic Oncology

DIA Europe 2024 to Confront Sustainability, Innovation, and Collaboration in Healthcare